EU backs development of molecular Dx test for malaria

09/25/2013 | GenomeWeb Daily News (free registration)

Forsite Diagnostics will use a $728,438 grant from the European Commission to support the development of a molecular test to diagnose malaria quickly. The company is developing the blood-based assay for use in detecting Plasmodium falciparum or Plasmodium vivaxis parasites, which trigger malaria, to help doctors prescribe appropriate treatments immediately.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park